PET scan to detect immune activity in cancer patients
Part of Cancer clinical trials.
This trial uses a special PET scan tracer to see where immune system signals are active in people with cancer. It may help doctors understand how your immune system is responding to the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have suspected, newly diagnosed, or a previous history of cancer.
- You are willing to sign a consent form.
- You are not pregnant.
- You do not have a known allergy to the tracer used in the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET scan using a tracer that attaches to certain markers (PSMA and FAP) found on some cancers. It aims to help doctors see where the cancer is, possibly leading to better treatment decisions.
This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.
This trial uses a special PET scan with a new tracer called 68Ga-DOTA-BLP to spot cancer and its spread in the body. It aims to see if this scan can find tumors in lymph nodes or other areas without needing more painful biopsies.
This trial uses a special PET scan called 68Ga-grazytracer to see how well immunotherapy is working in people with stomach, colon, or other gastrointestinal cancers. The goal is to find out if this scan can help doctors track your response to treatment.
This study uses a PET scan with a special radioactive tracer (68Ga-DOTA-Siglec-9) to look at cancer in certain people. It may help doctors better see cancer-related activity and guide treatment planning for selected cancers.
This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working for pancreatic cancer. It may help your doctor understand if your treatment is effective.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.